BIOTRONIK has decided to upgrade its BIOMONITOR injectable cardiac monitor and is releasing BIOMONITOR Ⅲ to replace BIOMONITOR Ⅱ.
BIOMONITOR Ⅲ is half the size of BIOMONITOR Ⅱ and offers much clearer signal quality. Injected under the skin to continuously monitor and record the patient’s electrical heart signals. It can remain under the skin for up to four years.
This new device will target the diagnosis of Atrial fibrillation so that the development of strokes, heart failure and other conditions can be avoided. It can also help in detection of cardiac arrhythmias and unexplained syncopes.
The cardiologists can spot arrhythmias more accurately using this newer version of the Monitor because it increases the signal amplitudes and the visibility of p-waves more significantly than the previous version of the device.
Mr Vinod Arora, Principal Advisor, IGMPI
Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like